Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18897885

Randomized trial of the combination of lomeguatrib and temozolomide compared with temozolomide alone in chemotherapy naive patients with metastatic cutaneous melanoma

Author
RANSON, Malcolm; HERSEY, Peter; BAKA, Sofia; SEEBARAN, Augustus; SABHARWAL, Ami; WATSON, Amanda J; MARGISON, Geoffrey P; MIDDLETON, Mark R; THOMPSON, Damien; BEITH, Jane; MCARTHUR, Grant A; HAYDON, Andrew; DAVIS, Ian D; KEFFORD, Richard F; MORTIMER, Peter; HARRIS, Peter A
[1] Department of Medical Oncology, University of Manchester, United Kingdom
[2] Cancer Research UK Carcinogenesis Group, Paterson Institute for Cancer Research, Manchester, United Kingdom
[3] Kudos Pharmaceuticals, Cambridge, United Kingdom
[4] Cancer Research UK Medical Oncology Unit, Churchill Hospital, Oxford, United Kingdom
[5] Princess Alexandra Hospital, Brisbane, Australia
[6] Newcastle Melanoma Unit, Newcastle, Australia
[7] Royal Prince Alfred Hospital, Australia
[8] Westmead Institute for Cancer Research. University of Sydney at Westmead, Millenium Institute, Sydney, Australia
[9] Peter MacCallum Cancer Centre, Australia
[10] The Alfred Hospital, Australia
[11] Austin Health, Melbourne, Australia
Source

Journal of clinical oncology. 2007, Vol 25, Num 18, pp 2540-2545, 6 p ; ref : 21 ref

ISSN
0732-183X
Scientific domain
Medical oncology
Publisher
Lippincott Williams & Wilkins, Baltimore, MD
Publication country
United States
Document type
Article
Language
English
Keyword (fr)
Anticancéreux Cancérologie Chimiothérapie Essai clinique Etude comparative Homme Lomeguatrib Métastase Randomisation Stade avancé Traitement Témozolomide Alkyltransferase des alkylguanines Cancer de la peau Agent alkylant Inhibiteur enzyme Peau pathologie Tumeur maligne
Keyword (en)
Antineoplastic agent Cancerology Chemotherapy Clinical trial Comparative study Human Lomeguatrib Metastasis Randomization Advanced stage Treatment Temozolomide Skin cancer Alkylating agent Enzyme inhibitor Skin disease Malignant tumor
Keyword (es)
Anticanceroso Cancerología Quimioterapia Ensayo clínico Estudio comparativo Hombre Lomeguatrib Metástasis Aleatorización Estadio avanzado Tratamiento Temozolomida Cáncer de piel Agente alquilante Inhibidor enzima Piel patología Tumor maligno
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B04 Tumors

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B08 Dermatology / 002B08A Tumors of the skin and soft tissue. Premalignant lesions

Discipline
Dermatology Tumours
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
18897885

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web